VasoMedical, Inc. is a global leader in non-invasive healthcare solutions and products with the corporate office and manufacturing in Plainview, New York. We also have manufacturing facilities in China. Our proprietary core product line of Enhanced External Counterpulsation (EECP®) Therapy systems is the leading product in the non-invasive treatment of cardiovascular disease.
VasoMedical Global (VasoGlobal), has been established to manage the operations of the Company's recently acquired Chinese companies, as well as identify and manage potential accretive acquisitions the Company may consider. “The completion of our accretive acquisitions is an important step of our global strategy. The consolidation of resources and vertical integration of our businesses situates VasoMedical well in the rapidly changing and challenging medical marketplace to realize its vision to be a global leader.” - Dr. Jun Ma, President & CEO
BIOX Instruments Co., Ltd., is a leading developer and manufacturer of ambulatory monitoring devices. Located in Wuxi, Jiangsu, China, BIOX has been VasoMedical's partner on the BIOXTM series ECG Holter recorders and analysis software as well as ambulatory blood pressure monitoring systems.
Life Enhancement Technologies (LET), based in Foshan, Guangdong, China, has been a technology and alternate manufacturing source for VasoMedical's proprietary Enhanced External Counterpulsation (EECP®) Therapy systems, including certain LumenairTM systems and all AngioNew® systems for over 15 years.